FR2313029B1 - - Google Patents

Info

Publication number
FR2313029B1
FR2313029B1 FR7608070A FR7608070A FR2313029B1 FR 2313029 B1 FR2313029 B1 FR 2313029B1 FR 7608070 A FR7608070 A FR 7608070A FR 7608070 A FR7608070 A FR 7608070A FR 2313029 B1 FR2313029 B1 FR 2313029B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7608070A
Other languages
French (fr)
Other versions
FR2313029A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT21493/75A external-priority patent/IT1049373B/it
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2313029A1 publication Critical patent/FR2313029A1/fr
Application granted granted Critical
Publication of FR2313029B1 publication Critical patent/FR2313029B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7608070A 1975-03-21 1976-03-19 Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique Granted FR2313029A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21493/75A IT1049373B (it) 1975-03-21 1975-03-21 Fluoro prostaglandine
IT149375 1975-03-21

Publications (2)

Publication Number Publication Date
FR2313029A1 FR2313029A1 (fr) 1976-12-31
FR2313029B1 true FR2313029B1 (en:Method) 1979-09-21

Family

ID=26325130

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608070A Granted FR2313029A1 (fr) 1975-03-21 1976-03-19 Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique

Country Status (10)

Country Link
US (4) US4338332A (en:Method)
AT (1) AT351189B (en:Method)
AU (1) AU501803B2 (en:Method)
BE (1) BE839789A (en:Method)
CA (1) CA1103663A (en:Method)
CH (2) CH629769A5 (en:Method)
DE (1) DE2611788C2 (en:Method)
FR (1) FR2313029A1 (en:Method)
GB (1) GB1493557A (en:Method)
NL (1) NL7602862A (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51877A (en) * 1976-06-01 1981-09-13 Carlo Erba Sa -nor-16-benzyl or phenoxy-13,14-dehydro-prostaglandins and process for their preparation
DE3004795A1 (de) * 1980-02-07 1981-08-13 Schering Ag Berlin Und Bergkamen, 1000 Berlin Neue prostacyclinderivate, ihre herstellung und anwendung
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
SU1256394A1 (ru) * 1984-04-24 1987-06-07 Институт Органического Синтеза Ан Латвсср Производные 15( @ + @ )-фтор-11,15-дидезоксипростагландина @ ,обладающие антиагрегационной активностью
WO1992018473A1 (fr) * 1991-04-22 1992-10-29 Taisho Pharmaceutical Co., Ltd. Analogue de prostaglandine e¿1?
CA2269855A1 (en) * 1996-11-12 1998-05-22 Alcon Laboratories, Inc. 15-fluoro prostaglandins as ocular hypotensives
AU1601602A (en) * 2000-11-30 2002-06-11 Akzo Nobel Nv Coating composition comprising a bicyclo-orthoester-functional compound, an isocyanate-functional compound, and a thiol-functional compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959346A (en) * 1969-03-14 1976-05-25 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
US3862979A (en) * 1972-06-15 1975-01-28 Erba Carlo Spa 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives
US3933899A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE2 -oxa-phenylene compounds
US3914282A (en) * 1973-01-16 1975-10-21 Upjohn Co Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
JPS5720305B2 (en:Method) * 1973-02-28 1982-04-27
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IT1037126B (it) * 1975-03-14 1979-11-10 Erba Carlo Spa 13.4 deidro ii desossi prosta glandine

Also Published As

Publication number Publication date
CA1103663A (en) 1981-06-23
GB1493557A (en) 1977-11-30
CH623570A5 (en:Method) 1981-06-15
DE2611788A1 (de) 1976-09-30
FR2313029A1 (fr) 1976-12-31
US4229585A (en) 1980-10-21
BE839789A (fr) 1976-07-16
DE2611788C2 (de) 1986-03-27
AU1191776A (en) 1977-09-15
US4338249A (en) 1982-07-06
ATA204576A (de) 1978-12-15
NL7602862A (nl) 1976-09-23
AT351189B (de) 1979-07-10
US4320143A (en) 1982-03-16
US4338332A (en) 1982-07-06
CH629769A5 (de) 1982-05-14
AU501803B2 (en) 1979-06-28

Similar Documents

Publication Publication Date Title
FR2313029B1 (en:Method)
FR2299186B3 (en:Method)
JPS51122853U (en:Method)
FR2310142B3 (en:Method)
AU7887375A (en:Method)
JPS5260474U (en:Method)
JPS5545746Y2 (en:Method)
JPS51100657U (en:Method)
JPS51103234U (en:Method)
JPS51126796U (en:Method)
JPS51159933U (en:Method)
CH602088A5 (en:Method)
CH590622A5 (en:Method)
BG22314A1 (en:Method)
CH601519A5 (en:Method)
CH598127A5 (en:Method)
CH597057A5 (en:Method)
CH596645A5 (en:Method)
BG22469A1 (en:Method)
BG22129A1 (en:Method)
CH595212A5 (en:Method)
BG22012A1 (en:Method)
CH594585A5 (en:Method)
CH592982A5 (en:Method)
CH592314A5 (en:Method)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse